Results 91 to 100 of about 1,117 (120)

Therapeutic properties of plant-derived prebiotics in melanoma. [PDF]

Explor Target Antitumor Ther
Kay E, Kazi M, Burton J, Parvathy SN.
europepmc   +1 more source

Bioactive compounds as therapeutic modulators of metabolic syndrome: targeting inflammation and gut microbiota regulation. [PDF]

Front Physiol
Udobi ME, Bella-Omunagbe M, Afolabi IS, Chinedu SN.   +3 more
europepmc   +1 more source

Nutritional strategies in supporting immune checkpoint inhibitor, PI3K inhibitor, and tyrosine kinase inhibitor cancer therapies. [PDF]

Front Nutr
Fuller-Shavel N, Davies EJ, Peleg Hasson S.   +2 more
europepmc   +1 more source

Anchoring ALS Prognosis: Neurofilament Light Chain Outperforms Inflammatory, Metabolic, and CNS Barrier Biomarkers in the METABALS Cohort. [PDF]

Mol Neurobiol
Alarcan H, Veyrat-Durebex C, Pradat PF, Cassereau J, Destee A, Couratier P, Camu W, Neau JP, Fleury-Lesaunier MC, Emond P, Dufour D, Al Ojaimi Y, Lefèvre A, Vourc'h P, Corcia P, Andres CR, Blasco H.   +16 more
europepmc   +1 more source

The potential use of hydrogen in the extraction of phytochemicals from neglected and underutilized plant species for enhanced human nutrition. [PDF]

Front Nutr
Uçarer E, Hüdaverdi YA, Elnasanelkasim MA, Kavrut E, Alkan S, Bekbayev K, Toleugazykyzy A, Bolkenov B, Bekbayeva R, Samadun A, Alwazeer D.   +10 more
europepmc   +1 more source

Nutritional Composition, Pharmacological Properties, and Industrial Applications of <i>Myrciaria dubia</i>: An Undiscovered Superfruit. [PDF]

Food Sci Nutr
Maqsood S, Arshad MT, Ikram A, Gnedeka KT.   +3 more
europepmc   +1 more source

Dietary Fiber and Melanoma: Exploring Microbiome-Driven Immune Modulation. [PDF]

Cancers (Basel)
Turner L, Sisk CK, Yusuf N.
europepmc   +1 more source

Phytotherapy with Fruit Seed Extracts as a Promising Approach for the Treatment of Inflammation. [PDF]

Curr Nutr Rep
Hirsa M, Fichna J, Tarasiuk-Zawadzka A.
europepmc   +1 more source

Mitigation strategies for gastrointestinal (GI) immune-related adverse events for patients with solid tumors receiving immunotherapy. [PDF]

Immunotherapy
Lasagna A.
europepmc   +1 more source

Abuse potential assessment of novel central nervous system active and psychedelic substances for controlled substances act scheduling recommendations. [PDF]

J Psychopharmacol
Henningfield JE, Comer SD, Banks ML, Coe MA, Collins GT, Cooper ZD, Fantegrossi WE, Durgin CJ, Heal DJ, Huskinson SL, Lanier RK, Lynch WJ, Meisch RA, Rowlett JK, Strickland JC, Gannon BM.   +15 more
europepmc   +1 more source